Multimarker risk stratification approach and cardiovascular outcomes in patients with stable coronary artery disease undergoing elective percutaneous coronary intervention
- PMID: 26896268
- PMCID: PMC4759483
- DOI: 10.1016/j.ihj.2015.06.034
Multimarker risk stratification approach and cardiovascular outcomes in patients with stable coronary artery disease undergoing elective percutaneous coronary intervention
Abstract
Aims: We studied the utility of multimarker risk stratification approach to predict cardiovascular outcomes in patients with stable coronary artery disease, undergoing elective percutaneous coronary intervention (PCI).
Methods: We prospectively evaluated 302 consecutive patients with stable coronary artery disease and normal CPK-MB and cardiac troponin T levels, and who underwent elective PCI at our institution. The following cardiac biomarkers were measured before and between 12 and 24h post-procedure: CK-MB, cardiac troponin T, hs-CRP, and NT-ProBNP. Patients were followed up for a minimum of 6 months.
Results: Post-PCI, CPK-MB levels were elevated but below myocardial infarction (MI) range in 70 patients (23%), and in the MI range in 6 patients (2%). Troponin T levels were detectable but below the 99th percentile (microleak) in 32 patients (10.6%) and elevated above the 99th percentile (periprocedural MI) in 104 patients (34.4%). At 9 months' follow-up, 1% died, 2% had stable angina, 10.3% had non-fatal MI, and 87.7% remained asymptomatic. There was no significant difference in clinical events among groups stratified by elevation of one biomarker or multiple biomarkers.
Conclusion: Single or multiple biomarker strategy in patients with normal baseline biomarkers failed to predict major cardiac events after PCI over medium-term follow-up.
Keywords: Biomarkers; Major adverse cardiovascular event; Percutaneous coronary intervention; Periprocedural myocardial infarction.
Copyright © 2015 Cardiological Society of India. Published by Elsevier B.V. All rights reserved.
Figures
Similar articles
-
The effect of intravenous vitamin C infusion on periprocedural myocardial injury for patients undergoing elective percutaneous coronary intervention.Can J Cardiol. 2014 Jan;30(1):96-101. doi: 10.1016/j.cjca.2013.08.018. Can J Cardiol. 2014. PMID: 24365194 Clinical Trial.
-
Type 4a myocardial infarction: Incidence, risk factors, and long-term outcomes.Catheter Cardiovasc Interv. 2017 Apr;89(5):849-856. doi: 10.1002/ccd.26688. Epub 2016 Aug 18. Catheter Cardiovasc Interv. 2017. PMID: 27535209
-
Impact of Periprocedural Myocardial Biomarker Elevation on Mortality Following Elective Percutaneous Coronary Intervention.JACC Cardiovasc Interv. 2019 Oct 14;12(19):1954-1962. doi: 10.1016/j.jcin.2019.07.014. JACC Cardiovasc Interv. 2019. PMID: 31601389
-
Prognostic value of troponin after elective percutaneous coronary intervention: A meta-analysis.Catheter Cardiovasc Interv. 2008 Feb 15;71(3):318-24. doi: 10.1002/ccd.21345. Catheter Cardiovasc Interv. 2008. PMID: 18288753 Review.
-
The prognosis of periprocedural myocardial infarction after percutaneous coronary interventions.Cardiovasc Revasc Med. 2013 Jan-Feb;14(1):32-6. doi: 10.1016/j.carrev.2012.10.006. Epub 2012 Nov 17. Cardiovasc Revasc Med. 2013. PMID: 23164601 Review.
Cited by
-
The effect of percutaneous coronary revascularization on plasma N-terminal pro-B-type natriuretic peptide levels in stable coronary artery disease.Indian Heart J. 2018 Mar-Apr;70(2):282-288. doi: 10.1016/j.ihj.2017.08.005. Epub 2017 Aug 16. Indian Heart J. 2018. PMID: 29716708 Free PMC article.
-
Potential impacts of high-sensitivity creatine kinase-MB on long-term clinical outcomes in patients with stable coronary heart disease.Sci Rep. 2020 Mar 27;10(1):5638. doi: 10.1038/s41598-020-61894-3. Sci Rep. 2020. PMID: 32221337 Free PMC article.
References
-
- Cuculi C., Lim C.C., Banning A.P. Periprocedural myocardial injury during elective percutaneous coronary intervention: is it important and how can it be prevented? Heart. 2010;96:736–740. - PubMed
-
- Miller W.L., Garratt K.N., Burritt M.F. Baseline troponin level: key to understanding the importance of post-PCI troponin elevations. Eur Heart J. 2006;27:1061–1069. - PubMed
-
- Thygesen K., Alpert J.S., White H.D., (Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction) Universal definition of myocardial infarction. Eur Heart J. 2007;28:2525–2538. - PubMed
-
- Ohman E.M., Armstrong P.W., Christenson R.H. Cardiac troponin T levels for risk stratification in acute myocardial ischemia. GUSTO IIA Investigators. N Engl J Med. 1996;335:1333–1341. - PubMed
-
- Antman E.M., Tanasijevic M.J., Thompson B. Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. N Engl J Med. 1996;335:1342–1349. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous